Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Ulta Beauty Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $23.3B | |
|---|---|---|
| Revenue (ttm) | 13B | |
| Net income (ttm) | 1.2B | |
| EPS (ttm) | $27.4 | |
| Shares out | 42.8M | |
| P/E (trailing) | 22.5x | |
| P/E (forward) | 19.6x | |
| Volume | 348,647 | |
| Beta | 0.84 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-29 | 2023-01-28 | 2024-02-03 | 2025-02-01 | 2026-01-31 | Trend |
| Revenue | $8.63B | $10.21B | $11.21B | $11.30B | $12.39B | +9.5% |
| Gross profit | $3.37B | $4.04B | $4.38B | $4.39B | $4.85B | +9.5% |
| Operating income | $1.30B | $1.64B | $1.68B | $1.56B | $1.53B | +4.3% |
| Net income | $985.8M | $1.24B | $1.29B | $1.20B | $1.15B | +4.0% |
| EPS (diluted) | $17.98 | $24.01 | $26.03 | $25.34 | $25.64 | +9.3% |
| EBITDA | $1.57B | $1.88B | $1.94B | $1.85B | $1.83B | +4.0% |
| R&D | $926.0K | $1.0M | $889.0K | $306.0K | — | -30.9% |
| SG&A | $2.06B | $2.40B | $2.69B | $2.81B | $3.30B | +12.5% |
Recent company headlines from major financial publishers.
Net sales compound moderately and operating margins remain stable. Store-fulfilled digital orders leverage retail fixed overhead, counterbalanced by persistent promotional activity. Substantial free cash flow generation and disciplined share repurchases support steady per-share compounding through FY2028.
Prestige beauty product innovation, category expansion into wellness routines, and store-fulfilled digital efficiencies drive accelerating comparable store sales growth and operating margin expansion, supporting robust earnings compounding alongside authorized capital return programs.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.2% | $520 | $532 | $544 | $558 | $573 |
| 8.7% | $493 | $502 | $513 | $524 | $536 |
| 9.2% | $470 | $477 | $486 | $495 | $505 |
| 9.7% | $449 | $456 | $463 | $470 | $479 |
| 10.2% | $431 | $437 | $443 | $449 | $456 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |